Novo's Rybelsus, check. Here are the major launches coming up next

Novo Nordisk won FDA approval for oral semaglutide. Meanwhile, other drugmakers are gearing up to launch highly anticipated drug candidates. Novartis, Allergan, Celgene and GSK have big rollouts expected this year, a new report from OptumRx shows.